


Searching News Database: Pap smear
HSMN NewsFeed - 8 Jun 2020
Arbor Vita Launches Open Platform COVID-19 Antibody Test Expanding Access To Higher Quality Diagnostics
Arbor Vita Launches Open Platform COVID-19 Antibody Test Expanding Access To Higher Quality Diagnostics
HSMN NewsFeed - 18 Sep 2013
Atossa Genetics Signs Distribution Agreement With McKesson Medical-Surgical
Atossa Genetics Signs Distribution Agreement With McKesson Medical-Surgical
HSMN NewsFeed - 21 Dec 2012
Christopher S. Destro Joins Atossa Genetics as Vice President of Sales and Marketing
Christopher S. Destro Joins Atossa Genetics as Vice President of Sales and Marketing
HSMN NewsFeed - 13 Jan 2009
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection
HSMN NewsFeed - 30 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
HSMN NewsFeed - 28 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
HSMN NewsFeed - 20 May 2008
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection from Cervical Disease than the Pap
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection from Cervical Disease than the Pap
HSMN NewsFeed - 14 May 2008
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
HSMN NewsFeed - 10 Mar 2008
GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
HSMN NewsFeed - 15 Nov 2007
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
HSMN NewsFeed - 17 Oct 2006
UNM Scientists Receive Funding for New Non-Invasive Endometrial Cancer Test
UNM Scientists Receive Funding for New Non-Invasive Endometrial Cancer Test
HSMN NewsFeed - 29 Sep 2006
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
Additional items found! 30
Members Archive contains
30 additional stories matching:
Pap smear
(Password required)
Pap smear
(Password required)
